Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to share news the company has posted its year end 2023 financial numbers that showed for the first time in company history, Delivra Health achieved positive Adjusted EBITDA. Delivra Health achieved positive Adjusted EBITDA, indicating a significant improvement in its financial performance. The positive Adjusted EBITDA is attributed to various factors, including increased net revenue driven by higher sales in the USA.
The company saw A 20% increase in net revenue compared to the previous year, with a significant contribution from the US market. A gross profit margin of 49%, representing a substantial improvement from the 32% margin reported in the previous fiscal year. This improvement is due to lower sales fees, reduced indirect cost of sales relative to increased sales, and a decrease in financial inventory write-downs. Delivra also reported a remarkable 119% year-over-year improvement in adjusted EBITDA, indicating enhanced profitability. Davey emphasized that the company's focus moving forward is to continue increasing revenue and profitability across multiple markets, including Canada, the USA, international markets, and e-commerce channels. Delivra Health's portfolio includes innovative brands like Dream Water and LivRelief, offering relief from common health issues such as sleeplessness, chronic pain, and anxiety.